Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Trial Profile

Secondary Prevention of Small Subcortical Strokes (SPS3) Trial

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jul 2017

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms SPS3
  • Most Recent Events

    • 20 Jul 2017 Results (n=2916) assessing cognitive function, presented at the Alzheimer's Association International Conference 2017.
    • 17 Feb 2016 Results (Levels of Inflammatory Markers in the Treatment of Stroke (LIMITS) study) published in the Stroke (n = 1244).
    • 13 Jan 2016 Results of post hoc analysis published in the Circulation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top